CAMBRIDGE, Mass.--(BUSINESS WIRE)--Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today the financial results for the third quarter and nine months ended September 30, 2008. In a conference call scheduled for 10:00 a.m., Eastern Daylight Time, the Company will also discuss the positive Zemiva Phase 2b clinical trial data recently presented at the American Heart Association Annual Meeting on November 9th and provide an update on program developments.
